Actively Recruiting
Feasibility and Acceptability of Mindful Self-Compassion Among Transgender and Nonbinary Young Adults
Led by University of Rhode Island · Updated on 2025-07-11
50
Participants Needed
1
Research Sites
167 weeks
Total Duration
On this page
Sponsors
U
University of Rhode Island
Lead Sponsor
N
National Center for Complementary and Integrative Health (NCCIH)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this single-arm feasibility study is to evaluate the feasibility and acceptability of an 8-week mindful self-compassion intervention and associated data-collection plan among transgender and nonbinary young adults. Participants will be asked to: * Complete weekly 2.5-hour virtual classes for 8 weeks and a 4-hour virtual retreat * Practice specific activities in between classes for 20-30 minutes a day * Answer survey questions before starting the intervention, half-way through the intervention, after the intervention, and 3-months after the intervention ends.
CONDITIONS
Official Title
Feasibility and Acceptability of Mindful Self-Compassion Among Transgender and Nonbinary Young Adults
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Identify as transgender, nonbinary, genderqueer, or another non-cisgender identity
- Have reliable access to a smartphone, computer, or tablet and the Internet
- Are reasonably able to make the time commitment required for the program (self-reported)
- Speak and understand English
You will not qualify if you...
- Have had formal mindfulness training or practice mindfulness regularly (15 minutes more than twice a week) in the last six months
- Score 15 or higher on the Patient Health Questionnaire-8 (PHQ-8)
- Score 2 or higher on the Columbia Suicide Severity Rating Scale
- Experienced an acute physical health crisis (e.g., chemotherapy, severe injury recovery) in the past year
- Had head trauma, seizure, or loss of consciousness in the past 6 months
- Have a history of trauma and score 14 or higher on the Post-Traumatic Checklist, 6-item Civilian version
- Have a diagnosis of personality disorder, schizophrenia, or history of psychosis
- Experienced an acute panic attack in the past month or severe social anxiety making class attendance difficult
- Had an acute episode of psychosis or suicide attempt in the past 12 months
- Engaged in non-suicidal self-injury in the past 6 months
- Are currently prescribed antipsychotic medications, benzodiazepines (equivalent to 30mg diazepam/day), or opioids (>40mg morphine equivalent/day)
- Have had recent changes or anticipated changes in psychiatric medication dose within specified timeframes
- Engage in harmful drinking patterns or have concerns about substance use during sessions
- Underwent detoxification from alcohol or drugs and have been in remission for less than 1 year
- Have been hospitalized overnight for mental health reasons in the past year or have bipolar disorder with recent episodes
- Experience other acute physical or mental illness symptoms that may make group participation difficult
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
N/A-- All study activities being conducted virtually
Providence, Rhode Island, United States, 02903
Actively Recruiting
Research Team
J
Jordon D Bosse, PhD, RN
CONTACT
H
Heather Paskalides
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
BASIC_SCIENCE
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here